Ginsenoside Rh2, a putative functional modulator of Annexin A2, attenuates post-hemorrhagic stroke cerebral edema via inhibiting vesicular transcytosis
4 affiliations
- 1Department of Pathology and Pathophysiology, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
- 2Department of Physiology, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
- 3Research and Innovation Center, College of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
- 4Department of Public Health, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Abstract
Background: Intracerebral hemorrhage (ICH) causes mechanical damage and cerebral edema. Annexin A2, expressed in endothelial cells, regulates cerebral edema, but its mechanisms in ICH remain unclear. Methods: A mouse ICH model was established using collagenase VII-S. We measured Annexin A2 expression, transcytosis, and blood–brain barrier (BBB) permeability. AAV was used to specifically knock down Annexin A2 in cerebrovascular endothelial cells. Protein interactions were identified by co-immunoprecipitation and label-free LC-MS. Ginsenoside Rh2 was tested for effects on protein binding (biolayer interferometry and competition assays) and on neurological/motor function, BBB integrity, and transcytosis. Results: ICH increased Annexin A2 expression, transcytosis, and BBB permeability. Annexin A2 knockdown worsened neurological deficits and motor function, increased BBB permeability, exacerbated tight junction disruption, but significantly reduced transcytosis. Six cytoskeletal proteins, Alpha-actinin-4, Actin-related protein 2, Actin alpha skeletal muscle, Actin cytoplasmic 1, Actin cytoplasmic 2, and Myosin-9, interacted with Annexin A2. Rh2 reduced binding affinity between Annexin A2 and these proteins, specifically inhibiting Annexin A2–Alpha-actinin-4 binding. Rh2 treatment improved neurological and motor function, reversed BBB disruption and tight junction damage, and suppressed transcytosis without altering Annexin A2 expression. Conclusion: Annexin A2 knockdown inhibited transcytosis but disrupted tight junctions and aggravated edema. In contrast, Rh2 inhibited transcytosis and exerts potential protective effect tight junctions, which may suggest a trend toward alleviation of cerebral edema to a certain extent. Selectively targeting Annexin A2-mediated transcytosis may be a promising therapy for ICH.
Related
- Ginsenoside Re attenuates severe acute pancreatitis-associated acute lung injury by inhibiting pancreatic necroptosis-driven cfDNA release and pulmonary cGAS-STING activation
- Breviscapine attenuates myocardial ischemia-reperfusion injury by inhibiting ferroptosis via activation of NRF2/SLC7A11/GPX4 pathway
- Artesunate attenuates inflammation and neurological impairment in intracerebral hemorrhage mice by inhibiting microglia NLRP3/ASC/Caspase-1
- Huaier Attenuates Renal Injury in Type 2 Diabetic Nephropathy by Ameliorating Mitochondrial Dysfunction and Inhibiting Tubular Epithelial Cell Apoptosis.
- Polygonatum sibiricum polysaccharide attenuates BMSC senescence by inhibiting NCOA4-mediated ferritinophagy.
BibTeX
@article{han2026ginsenoside,
title = {{Ginsenoside Rh2, a putative functional modulator of Annexin A2, attenuates post-hemorrhagic stroke cerebral edema via inhibiting vesicular transcytosis}},
author = {Xu Han and Chu Li and Qianlin Li and Haixia You and Feiyan Chen and Cuihua Chen and Qi Yao and Dongqing Yang and Lin Chen and Zhu Zhu and Yunan Zhao},
journal = {Journal of Ginseng Research},
year = {2026},
month = aug,
doi = {10.1016/j.jgr.2026.101148},
url = {https://doi.org/10.1016/j.jgr.2026.101148},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Ginsenoside Rh2, a putative functional modulator of Annexin A2, attenuates post-hemorrhagic stroke cerebral edema via inhibiting vesicular transcytosis
AU - Xu Han
AU - Chu Li
AU - Qianlin Li
AU - Haixia You
AU - Feiyan Chen
AU - Cuihua Chen
AU - Qi Yao
AU - Dongqing Yang
AU - Lin Chen
AU - Zhu Zhu
AU - Yunan Zhao
PY - 2026
DA - 2026/08/28
JO - Journal of Ginseng Research
DO - 10.1016/j.jgr.2026.101148
UR - https://doi.org/10.1016/j.jgr.2026.101148
AB - Background: Intracerebral hemorrhage (ICH) causes mechanical damage and cerebral edema. Annexin A2, expressed in endothelial cells, regulates cerebral edema, but its mechanisms in ICH remain unclear. Methods: A mouse ICH model was established using collagenase VII-S. We measured Annexin A2 expression, transcytosis, and blood–brain barrier (BBB) permeability. AAV was used to specifically knock down Annexin A2 in cerebrovascular endothelial cells. Protein interactions were identified by co-immunoprecipitation and label-free LC-MS. Ginsenoside Rh2 was tested for effects on protein binding (biolayer interferometry and competition assays) and on neurological/motor function, BBB integrity, and transcytosis. Results: ICH increased Annexin A2 expression, transcytosis, and BBB permeability. Annexin A2 knockdown worsened neurological deficits and motor function, increased BBB permeability, exacerbated tight junction disruption, but significantly reduced transcytosis. Six cytoskeletal proteins, Alpha-actinin-4, Actin-related protein 2, Actin alpha skeletal muscle, Actin cytoplasmic 1, Actin cytoplasmic 2, and Myosin-9, interacted with Annexin A2. Rh2 reduced binding affinity between Annexin A2 and these proteins, specifically inhibiting Annexin A2–Alpha-actinin-4 binding. Rh2 treatment improved neurological and motor function, reversed BBB disruption and tight junction damage, and suppressed transcytosis without altering Annexin A2 expression. Conclusion: Annexin A2 knockdown inhibited transcytosis but disrupted tight junctions and aggravated edema. In contrast, Rh2 inhibited transcytosis and exerts potential protective effect tight junctions, which may suggest a trend toward alleviation of cerebral edema to a certain extent. Selectively targeting Annexin A2-mediated transcytosis may be a promising therapy for ICH.
SN - 1226-8453
SN - 2093-4947
ER -